ABSTRACT
INTRODUCTION
Ribonucleoproteins (RNPs) have been implicated in an array of biological processes within the cell. These include established roles in RNA processing and translation, as well as more recently discovered functions relevant to synthesis of chromosomal telomeres (1) and organellar DNA replication (2) . RNase MRP is an RNP present in both the nucleus and mitochondria of vertebrate cells that can act as a site-specific endonuclease in vitro. This endonuclease has been implicated in the metabolism of RNA primers at one of the origins of DNA replication in the vertebrate mitochondnal genome (3) ; the RNA component of this RNP (MRP RNA) is encoded by a nuclear gene (4, 5) .
The original description of mouse MRP RNA species revealed a 275-nucleotide (nt) transcript present in both nuclear RNA and mitochondnal RNA (mtRNA) populations and a smaller RNA, corresponding to the 3' half of this molecule, which was preferentially isolated with mitochondrial RNase MRP isolates (4) . This smaller form of MRP RNA appeared to copurify with the endonucleolytic activity from mouse mitochondria and was thus designated as the active species within the endonuclease. Recently it has become clear that full length MRP RNA is identical to the previously described 7-2 or Th RNA (see ref. 6 ). This species is precipitable by a unique class of autoimmune sera and is believed to be localized to the granular region of the nucleolus, prompting speculation on its possible role in nbosomal biogenesis. RNase MRP also appears to be related antigenically to RNase P in mammalian cells. This situation raises a number of questions regarding the biology of this RNA and the enzymatic RNP. Is the RNP containing the full length MRP RNA capable of acting as a site-specific endonuclease? What are the respective roles of the full length MRP RNA and its smaller cleavage product within the cell?
One approach to these questions is to examine MRP RNPs from distinct species to identify aspects of the system that are conserved and thus likely important in understanding the role of this RNP within the cell. RNase MRP was originally identified in mouse cells, and the murine system has been the only one for which any information regarding the nature of this enzyme was available. This report details the characterization of human MRP RNA and its nuclear gene. Comparison of the human gene with its counterpart from mouse reveals a significant amount of sequence similarity within both the RNA coding sequence and the upstream transcriptional control region. Although the human MRP RNA also is subject to a cleavage event generating a smaller form of the RNA, the site of cleavage is offset relative to that of mouse. Analysis of RNase MRP endonucleolytic activity from human cells reveals that the nuclear form of this enzyme is present in greater abundance than determined previously (4). Furthermore, oligonucleotide-mediated inhibition studies of both mouse and human enzymes show that the RNP containing the full length MRP RNA is active as a site-specific endonuclease.
MATERIALS AND METHODS
Isolation of the MRP RNA gene and RNA analysis A human placental DNA genomic library in Charon 4A (kindly provided by M.L. Cleary, Stanford) was screened as described (7) . The 1.04 kb Pstl fragment encompassing the region coding for the MRP RNA was sequenced in its entirety on both strands. 5' and 3' probes for SI analysis were prepared by labeling the 1.04-kb Psil fragment at an internal Accl site. Hybridization and SI digestion conditions were as in Maniatis et al. (7) . RNA termini were determined by electrophoresis of the S1 digestion products adjacent to Maxam-Gilbert sequence ladders. RNA sequencing with complementary oligonucleotides and reverse transcriptase was performed as described in Parker and Steitz (8) . The oligonucleotides used were complementary to nucleotides 90-129 and 229-265 of the human MRP RNA. Primer extensions were performed without the addition of dideoxynucleotides. For the primer extension analyses of Figure  5 , primers complementary to nucleotides 70-83 of human MRP RNA and nucleotides 90-139 of mouse MRP RNA were used. Northern analysis was performed as in Chang and Clayton (4) . Hybridization conditions were 4x SSPE, 40% formamide, 5x Denhardt's solution, 200 /*g/ml tRNA, 1.0 mM pyrophosphate, 0.1 % SDS at 42 °C. The probes were generated by 5'-end labeling the oligonucleotide or nick translating the MRP RNA gene as described (7) . The blot was washed in 0.1 x SSPE, 0.1 % SDS at 60°C.
Oligonucleotide inhibition of RNase MRP
Extracts from human KB cell or mouse LA9 cell mitochondria were fractionated by glycerol gradient sedimentation as described (4) . Fractions containing RNase MRP activity as assayed on the mouse mtRNA substrate (3) were pooled. For the oligonucleotidemhibition experiments involving Oligo 2C (Fig. 4A) , enzyme fractions were preincubated with either 25 or 50 fiM of the oligonucleotide for 3 hr at 4°C. Aliquots were then removed and assayed as described (4) . For the experiments involving Oligos H and M (Fig. 4B ,C) mis protocol was modified; enzyme fractions were incubated with 20 /tM of the appropriate oligonucleotide for 3 hr at 4°C and the samples were then incubated at 37 °C for 20 min and RNase H was added to the appropriate samples. Aliquots were then removed for assay as above. RNase H was purchased from Bethesda Research Laboratories. Cleavage of the substrate was assayed by electrophoresis on denaturing gels as described. The sequences of the oligonucleotides used were: Oligo 2C, 5'-TCTCTGTGT-GAGCTGACAAA-3'; Oligo H, 5'-GGGAGGAACAGAGTC-3'; Oligo M, 5'-GATAAGGAACATGTC-3'; and, 33-mer, 5'-CCTTCAGAGCGAGCTCTATAGTGAGTCGTATTA-3' 
RESULTS

Significant features of RNase MRP RNA genes and their putative control regions
The human MRP RNA gene was cloned by screening a human genomic library in Charon 4A with both the mouse MRP RNA gene and an oligonucleotide complementary to nucleotides 90 through 139 of the mouse MRP RNA (5). Five individual phage comprising three classes were isolated and each was found to contain the same 1.04-kb Pstl fragment that hybridized with the oligonucleotide. This fragment was sequenced and contained the coding region for the human MRP RNA gene (see below). Figure  1 contains the sequence of the noncoding strand from nucleotides -715 to +293 with respect to the start site of transcription; the sequence has been aligned with that of mouse with gaps introduced in both sequences (indicated by dots) in order to maximize the proposed similarities. Nucleotides below the human sequence represent positions in which the mouse sequence differs from that of human; the sequence of the human MRP RNA is shown above the DNA sequence. Inspection reveals a high degree of conservation between the human and mouse loci. The coding regions of the two RNAs are approximately 84% identical; this is slightly less than the 90-95% conservation between human and mouse observed for members of the U series of small nuclear RNAs (snRNAs) (9) . The MRP RNA genes of the two species are also very similar as far as 715 bp upstream; they are approximately 70% conserved in the 5'-flanking sequences shown. This conservation is greatest in the regions from -390 to -510 and -580 to -715 where the degree of similarity is approximately 85 %, comparable to the level found in the coding regions of the two genes. The extent of conservation between the upstream regions of the human and mouse MRP RNA genes is significantly greater than that found in the upstream regions of the genes for the human and mouse U series of snRNAs. The 5'-flanking regions of the latter gene are only about 50% conserved and this conservation is limite to a few hundred base pairs upstream of the start sites. Indeec even the genes for the different U-series snRNA families withi humans display only a limited amount of 5'-sequence conservatio that is confined to within a few hundred nucleotides of the sta sites (9) . Thus the genes for the MRP RNA appear to be uniqii among the genes for small RNAs in possessing highly conserve 5'-flanking regions.
A variety of putative transcriptional regulatory elements ai present in the 5'-flanking sequence of the human MRP RN gene. Among these are a number of sequences resemblir transcriptional control elements thought to be important in tl expression of the U-series snRNAs, specifically U6 snRN (10, 11) . These include a TATA sequence at about -30, proximal sequence element at -65, and a putative distal sequeni element, which may consist of the octamer motif, situated 2] bp upstream, and one or more of the four possible Spl interactk sites situated from -220 to -400. The coding region contaii a good match for a Box A internal promoter sequence, tl nucleotides TGGT at the start site of transcription and ends ju upstream of a run of thymidine residues. All of these sequeni elements resemble those found in most U6 genes identified thi far and, with the possible exception of the internal Box A, th< have been shown to be important for accurate expression in vh or in vitro (9, 12) . The presence of these features in both the MF and U6 RNA genes is consistent with the MRP RNA gene beii an RNA polymerase III transcription unit (5) .
These U-series-like transcriptional elements are situatec relatively near the start of transcription; this raises the likelihooa that the highly conserved regions present upstream of these elements contain additional regulatory sequences. One candidate is a sequence closely resembling the nuclear respiratory factor 1 (NRF-1) binding site, located between -280 and -290. NRF-1 is a factor that binds to an element upstream of the gene for the nucleus-encoded mitochondrial protein cytochrome c and possibly within the first exon of the cytochrome c oxidase subunit Vic gene (13) .
Little or no homology exists downstream of the genes. This is due at least in part to the presence of a Bl repetitive element at the 3' end of the mouse MRP gene (5, 14) . The presence of this element, which probably resulted from a transposition event since the splitting of the human and mouse lineages, argues against immediately downstream sequences playing a critical role in the expression or function of these genes.
The gene for the human MRP RNA is present as a single copy. The evidence for this consists of Southern hybridization analysis, which demonstrates a single species in digests of human genomic DNA with a variety of restriction enzymes, as well as chromosomal localization studies involving in situ hybridization and analysis of somatic cell hybrids (15) . Figure 2 presents primer extension and SI nuclease protection analyses of human MRP RNA. These data, together with information derived from direct RNA sequencing of the human MRP RNA and hybrid selection of MRP RNA with the genomic clone (data not shown), demonstrate that this gene is expressed in human cells and is not a pseudogene, which are known to exist for other small RNA species (16) . The major species of human MRP RNA is 265-nt long; however, some 3'-end heterogeneity appears to be present. SI analysis assigned the major 3' nucleotide as U at position 265, but evidence of slightly longer species exists (6) . Many of the U-series snRNAs are synthesized as precursors with additional nucleotides at the 3' terminus which are then removed (see ref. 9); a similar phenomenon may be occurring in this instance. As in the case of mouse MRP RNA, the human 5' end is cappable with GTP and guanylyl transferase (data not shown). fraction. In addition to full length MRP RNA, a smaller species, designated 3', is present in significant amounts in the mitochondrial fraction. As the name implies, this species represents the 3'-108 nt of MRP RNA, resulting from a cleavage event between residues 157 and 158 (see Figs. 1 and 2B ). This 3' 108-nt species is reproducibly isolated from mitochondria at the level present in lane 2 of Figure 3 , whereas the relative amount present in nuclear MRP isolates ranges from below detection to the level in lane 1 of Figure 3 . The 5' half is also present as indicated by its ability to hybridize with the entire gene, but not with the 3'-specific probe (Fig. 3) . Two control probes, complementary to nuclear Ul snRNA and mitochondrial methionyl-tRNA (lanes 5 and 6), were used to assess the degree of cross-contamination of the nuclear and mitochondrial RNA isolates. The result was similar to that of mouse cells (4) in that >90% of each human species was localized to the appropriate fraction. Thus the majority of the 265-nt MRP RNA was in the nuclear RNA isolate and it appears that the ratio of the 265-nt to 108-nt species differs in the two cellular compartments. The presence of multiple RNA species is reminiscent of the mouse situation, where a cleavage event generates a small MRP RNA that co-isolates with mitochondria (4). The human system differs in two respects. First, cleavage does not occur at the same position (Fig. 2B) , despite the good conservation of RNA sequence in this area (using the alignment of Fig. 1 ). Human MRP RNA is hydrolyzed 17 bases downstream relative to its mouse counterpart, although in both cases cleavage is exact and occurs at the sequence ANCCCGC. The second difference is the presence of the 5' half of the RNA molecule; this species was not detected in RNA isolates from mouse cells (4). 
Properties of the human RNase MRP RNA
Specific oligonucleotide-mediated inhibition of RNase MRP
Within the mitochondrion RNase MRP is involved in the processing of RNA primers at the origin of leading-strand DNA replication. In vitro, the partially purified MRP RNP will cleave specifically a single-stranded RNA molecule derived from this origin in a manner consistent with this function (3). The RNase MRP activity isolated from human cells appears to be very similar to the mouse enzyme. Biochemical analysis of this activity reveals that the behavior of the human MRP RNP over a number of ion exchange columns (including DEAE, phosphocellulose and FPLC Mono Q) is the same as that of mouse (data not shown). In addition, overall substrate specificity is similar for human and mouse enzymes (17) . This close similarity in biochemical properties suggests that the various components of the two species' RNPs are themselves conserved. However, it is clear that the generation of the smaller form of the MRP RNA is not a strictly conserved process since the site of cleavage in the human system is offset from that of mouse, thereby generating a 3' product almost 30 bases shorter. In order to identify more definitively which RNAs were essential for enzymatic activity, oligonucleotide-mediated inhibition studies were performed. Previous work on the murine system showed that an oligonucleotide (designated 2C) complementary to a region in the 3' half of the MRP RNA was inhibitory (4). This oligonucleotide is also complementary to the human MRP RNA and its ability to inhibit the human enzyme activity was tested. Oligonucleotide 2C was able to inhibit the human enzyme, while a 33-mer of unrelated sequence was without effect (Fig. 4A) . Thus in humans, as for mouse, the 3' half of the molecule is essential for activity.
To determine whether the 5' half of the molecule is also required for activity, both human and mouse RNases MRP were incubated with oligonucleotides specific for a region in the 5' half of either human or mouse MRP RNA (Fig. 4B,C) . Oligonucleotide H, complementary to nucleotides 40 through 54 of the human MRP RNA, inhibits the human enzyme (Fig. 4B) . This inhibition occured both in the presence or absence of RNase H, but was more pronounced when exogenous RNase H was added (it should be noted that the presence of endogenous RNase H activities in the partially pure MRP fraction is not excluded). As a control, oligonucleotide M (complementary to nucleotides 41 through 55 of mouse MRP RNA) was tested for its ability to inhibit the human enzyme; it had significantly less effect than did oligonucleotide H when tested against the human RNase MRP. The converse is observed when these oligonucleotides are tested against enzyme derived from mouse cells (Fig. 4C) ; here only oligonucleotide M was strongly inhibitory. In both cases some decrease in activity is seen on treatment with the heterologous oligonucleotides; this is not unexpected. Since oligonucleotides H and M each contain a stretch of seven identical nucleotides and these experiments involved a prolonged incubation at low temperature (see MATERIALS AND METHODS), some interaction of the oligonucleotides with the heterologous RNA should be occurring. Thus the modest reduction in activity is likely due to either endogenous RNase H activity acting during the preincubation or incomplete melting of the heterologous RNA-DNA hybrids during the subsequent 37°C incubation prior to assay. Despite these effects, it is apparent from these analyses that specific oligonucleotides are able to inhibit selectively the homologous RNase MRP activity. The experiments shown were performed with extracts from mitochondria and similar results were found with enzyme isolated from nuclear extracts (data not shown).
To confirm that these oligonucleotides were directly targeting the MRP RNA for degradation by RNase H, we analyzed MRP RNA isolated from enzyme fractions that had been treated with oligonucleotides complementary to the 5' half of MRP RNA. This was accomplished by reverse transcription of RNA isolated from oligonucleotide-and RNase H-treated enzyme fractions. Specific primers complementary to the MRP RNA downstream of the target region of the inhibitory oligonucleotides were used. Cleavages resulting from oligonucleotide-mediated RNase H hydrolysis should be detectable by the synthesis of specific runoff transcripts during the primer extension reaction (Fig. 5) . Figure 5A , which may be due to endogenous RNase H action as posited above. These results, together with the cleavage inhibition data of Figure 4 , indicate tfiat the MRP RNA is an integral part of RNase MRP, and that the 5' half of the molecule, like the 3' half, is required for endonucleolytic activity. This constitutes the first demonstration that the full length MRP RNA, assembled into an RNP, is active as an endonuclease.
DISCUSSION
Determination of the basic properties of the human MRP RNA gene and its transcription products reveals some of the essential features of this novel RNP, which has recently been shown to be identical to the Th autoantigen (MRP/Th RNA) (6) . As anticipated, MRP/Th RNA genes of human and mouse are similar in size and sequence. Expression of these genes in mammalian cells may be complex as indicated by the presence of both polymerase II and polymerase HI ds-acting regulatory elements as well as the unexpected high degree of similarity well upstream of the coding region, to at least position -700. This latter feature is even more intriguing in the context of a presumptive polymerase HI transcription unit. 5'-flanking regions have been implicated in the control of polymerase Hi-mediated transcription, but only recendy have these been shown to be both necessary and sufficient; e.g., the U6 gene has been shown to possess approximately 200 bp of 5'-flanking sequence critical for expression (10, 11) . The MRP/Th RNA genes extend the potential control region to at least -700 bp. Thus polymerase in and its associated factors may be capable of recognizing sequences a substantial distance upstream of the transcnptional initiation site in addition to the well known intragenic control regions. Northern blot hybridization and nuclease protection assays have not revealed the existence of any additional transcripts complementary to the upstream region (unpublished observations). The full significance of this unique finding for the regulation, maintenance and organization of this genetic unit remains to be established.
The human MRP/Th RNA is 84% identical in sequence to that of mouse. It possesses a 5'-triphosphate terminus and is subject to a cleavage event that generates a smaller RNA. The RNase MRP activity from human cells is essentially identical to that of mouse in its biochemical properties. Thus it seems reasonable to assume that the two RNPs are very similar in both their constituent proteins and their overall structure. Interestingly, computer analysis of the structure of human MRP/Th RNA using the programs of Zuker and Stiegler (18) predicts a structure completely different from that for the mouse MRP/Th RNA despite the conservation of sequence (5) . Because the sequences are so similar, analysis of compensatory changes in nucleotides that could reveal the presence of conserved secondary structure elements is limited by the small number of changes in relevant regions. Knowledge of the secondary structure of these RNAs will require additional sequences and direct examination of the structure by experimental means (19) .
The results of the oligonucleotide-mediated inhibition experiments support the idea that the human MRP/Th RNA is an integral part of the MRP endonucleolytic activity present in human cells. These results also imply that the 5' portion of the 265-nt MRP/Th RNA molecule, which contains the region complementary to these inhibitory oligonucleotides, is important for enzymatic activity. Earlier work established the requirement for the 3' region of the molecule (4); taken together, these results support the concept that the full length 265-nt MRP/Th RNA (275-nt in mouse) is assembled into a catalytically active RNP. These data do not bear definitively on whether a liberated 3' portion of full size MRP/Th RNA can support an endonucleolytic event when assembled with protein, as has been suggested for mouse enzyme based on co-purification arguments (4) . A more complete resolution of the two RNAs in RNP form (or a genetic approach) should decide the issue of whether the 3' portion of MRP/Th RNA (108 nt in human, 136 nt in mouse) is sufficient to support any step of the cleavage reaction.
From this work it is now clear that me RNP containing the full length MRP/Th RNA is enzymatically active as a site-specific endonuclease. Furthermore, the nuclear compartment of the cell contains a significant amount of this RNP that is active in vitro. These facts raise the importance of developing strategies for assessing its possible function in the nuclear organelle. Based on the demonstrated ability of RNase MRP to act as a site-specific endonuclease, at least two possible functions can be proposed. The first is some role in pre-ribosomal RNA processing, an idea supported by the observation that MRP/Th RNP appears to be preferentially localized to the nucleolus (6, 20, 21) . However, our current knowledge of the substrate requirements of this endonuclease do not point to any obvious candidates for efficient processing sites within the currently available ribosomal RNA sequences (Bennett and Clayton, submitted).
Given its assigned role in mitochondnal primer RNA metabolism, a second hypothesis for a function of RNase MRP within the nucleus is some participation in nuclear DNA replication. As in the mitochondrion, it may be involved in the processing of RNA primers at origins of DNA replication. Resolution of these issues, and an understanding of the central intracellular targeting phenomenon that permits localization of this RNP in both the nucleus and mitochondria, will be aided by a more complete knowledge of the essentials of substrate requirement, the identity of RNase MRP protein components and the development of an in vitro reconstitution system.
